Autoregulation of glial cell line-derived neurotrophic factor expression: Implications for the long-lasting actions of the anti-addiction drug, Ibogaine

FASEB Journal

Volumn 20, Issue 13, 2006, Pages

  He, Dao Yao ^a   Ron, Dorit ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Gene expression; Growth factor; SHSY5Y

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; IBOGAINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN RET; AMINO ACID RECEPTOR BLOCKING AGENT; PSYCHEDELIC AGENT;

ALCOHOL CONSUMPTION; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG DEPENDENCE; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIA; HOMEOSTASIS; NEUROBLASTOMA; PHYSIOLOGY; TUMOR CELL LINE;

RODENTIA;

CELL LINE, TUMOR; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HALLUCINOGENS; HOMEOSTASIS; HUMANS; IBOGAINE; NEUROBLASTOMA; NEUROGLIA;

EID: 33845655479     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6394fje     Document Type: Article

References (35)

1. He, D. Y., McGough, N. N., Ravindranathan, A., Jeanblanc, J., Logrip, M. L., Phamluong, K., Janak, P. H., and Ron, D. (2005) Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J. Neurosci. 25, 619-628
2. Alper, K. R., Lotsof, H. S., Frenken, G. M., Luciano, D. J., and Bastiaans, J. (1999) Treatment of acute opioid withdrawal with ibogaine. Am. J. Addict. 8, 234-242
3. Sheppard, S. G. (1994) A preliminary investigation of ibogaine: case reports and recommendations for further study. J. Subst. Abuse Treat. 11, 379-385
4. Mash, D. C., Kovera, C. A., Buck, B. E., Norenberg, M. D., Shapshak, P., Hearn, W. L., and Sanchez-Ramos, J. (1998) Medication development of ibogaine as a pharmacotherapy for drug dependence. Ann. N. Y. Acad. Sci. 844, 274-292
5. Glick, S. D., and Maisonneuve, I. M. (2000) Development of novel medications for drug addiction. The legacy of an African shrub. Ann. N. Y. Acad. Sci. 909, 88-103
6. Glick, S. D., Rossman, K., Steindorf, S., Maisonneuve, I. M., and Carlson, J. N. (1991) Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur. J. Pharmacol. 195, 341-345
7. Cappendijk, S. L., and Dzoljic, M. R. (1993) Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur. J. Pharmacol. 241, 261-265
8. Glick, S. D., Kuehne, M. E., Raucci, J., Wilson, T. E., Larson, D., Keller, R. W., Jr., and Carlson, J. N. (1994) Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res. 657, 14-22
9. Glick, S. D., Rossman, K., Rao, N. C., Maisonneuve, I. M., and Carlson, J. N. (1992) Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor. Neuropharmacology 31, 497-500
10. Rezvani, A. H., Overstreet, D. H., and Lee, Y. W. (1995) Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats. Pharmacol. Biochem. Behav. 52, 615-620
11. Rezvani, A. H., Overstreet, D. H., Yang, Y., Maisonneuve, I. M., Bandarage, U. K., Kuehne, M. E., and Glick, S. D. (1997) Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats. Pharmacol. Biochem. Behav. 58, 615-619
12. O'Hearn, E., and Molliver, M. E. (1993) Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55, 303-310
13. O'Hearn, E., and Molliver, M. E. (1997) The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity. J. Neurosci. 17, 8828-8841
14. Mash, D. C., Kovera, C. A., Pablo, J., Tyndale, R. F., Ervin, F. D., Williams, I. C., Singleton, E. G., and Mayor, M. (2000) Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Ann. N. Y. Acad. Sci. 914, 394-401
15. Canossa, M., Griesbeck, O., Berninger, B., Campana, G., Kolbeck, R., and Thoenen, H. (1997) Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc. Natl. Acad. Sci. U. S. A. 94, 13279-13286
16. Righi, M., Tongiorgi, E., and Cattaneo, A. (2000) Brain-derived neurotrophic factor (BDNF) induces dendritic targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a phosphatidylinositol-3 kinase-dependent pathway. J. Neurosci. 20, 3165-3174
17. Xiong, H., Futamura, T., Jourdi, H., Zhou, H., Takei, N., Diverse-Pierluissi, M., Plevy, S., and Nawa, H. (2002) Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons. Neuropharmacology 42, 03-912
18. Airaksinen, M. S., and Saarma, M. (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383-394
19. Verity, A. N., Wyatt, T. L., Lee, W., Hajos, B., Baecker, P. A., Eglen, R. M., and Johnson, R. M. (1999) Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J. Neurosci. Res. 55, 187-197
20. Armstrong, K. J., and Niles, L. P. (2002) Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells. Neuro-Report 13, 473-475
21. Castro, L. M., Gallant, M., and Niles, L. P. (2005) Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J. Neurochem. 95, 1227-1236
22. Baecker, P. A., Lee, W. H., Verity, A. N., Eglen, R. M., and Johnson, R. M. (1999) Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene. Mol. Brain Res. 69, 209-222
23. Milanini, J., Vinals, F., Pouyssegur, J., and Pages, G. (1998) p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem. 273, 18165-18172
24. Beck, K. D., Irwin, I., Valverde, J., Brennan, T. J., Langston, J. W., and Hefti, F. (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16, 665-673
25. Kobori, N., Waymire, J. C., Haycock, J. W., Clifton, G. L., and Dash, P. K. (2004) Enhancement of tyrosine hydroxylase phosphorylation and activity by glial cell line-derived neurotrophic factor. J. Biol. Chem. 279, 2182-2191
26. Bourque, M. J., and Trudeau, L. E. (2000) GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur. J. Neurosci. 12, 3172-3180
27. 2+ channels and transmitter release. Neuron 32, 99-112
28. Yang, F., Feng, L., Zheng, F., Johnson, S. W., Du, J., Shen, L., Wu, C. P., and Lu, B. (2001) GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat. Neurosci. 4, 1071-1078
29. Gerlai, R., McNamara, A., Choi-Lundberg, D. L., Armanini, M., Ross, J., Powell-Braxton, L., and Phillips, H. S. (2001) Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur. J. Neurosci. 14, 1153-1163
30. Adams, J. P., and Sweatt, J. D. (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol. Toxicol. 42, 135-163
31. Thomas, G. M., and Huganir, R. L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183
32. Kelleher, R. J., 3rd, Govindarajan, A., Jung, H. Y., Kang, H., and Tonegawa, S. (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467-479
33. Messer, C. J., Eisch, A. J., Carlezon, W. A., Jr., Whisler, K., Shen, L., Wolf, D. H., Westphal, H., Collins, F., Russell, D. S., and Nestler, E. J. (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26, 247-257
34. Green-Sadan, T., Kinor, N., Roth-Deri, I., Geffen-Aricha, R., Schindler, C. J., and Yadid, G. (2003) Transplantation of glial cell line-derived neurotrophic factor-expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self-administration in rats. Eur. J. Neurosci. 18, 2093-2098
35. Green-Sadan, T., Kuttner, Y., Lublin-Tennenbaum, T., Kinor, N., Boguslavsky, Y., Margel, S., and Yadid, G. (2005) Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp. Neurol. 194, 97-105